Concierge Care for All: Yes, It Really Is That Simple
By MATTHEW HOLT & CLAUDE You’ll recall that a few weeks back I gave Claude…
Concierge Care for All: Yes, It Really Is That Simple
By MATTHEW HOLT & CLAUDE You’ll recall that a few weeks back I gave Claude some prompts and my entire corpus of work on THCB and asked it to write a piece. It was about 70% my ideas and 50% my writing tone. I’m back trying it again. This time I gave it a lot…
New Bill Seeks to Lower Out-of-Pocket Drug Costs
Rep. Greg Murphy introduced a bill that would require out-of-pocket prescription drug spending to count toward patients’ deductibles and out-of-pocket maximums regardless of where the drugs are purchased. The post New Bill Seeks to Lower Out-of-Pocket Drug Costs appeared first on MedCity News.
Impact of Continuous Glucose Monitoring on Clinical Outcomes and Productivity Losses Among People Living With Type 2 Diabetes Not Using Insulin From an Employer’s Perspective
That is the title of a new paper out yesterday in the Journal of Diabetes Science and Technology from my FTI colleague Marie Steele-Adjognon, along with Martha E. Shepherd, Jon Harris-Shapiro, David Hines, Abraham Lee and Yeesha Poon. The abstract is below. Background: This study evaluated the impact of continuous glucose monitoring (CGM) on health…
New Comprehensive AI Risk and Supply Chain Transparency Guide for Healthcare
New guide provides healthcare entities with strategies to enhance AI governance, improve procurement processes, and establish shared responsibility models with vendors to better manage AI-related cybersecurity risks
Why Innovaccer Is Pouring $250M into Its Agentic AI Platform
Innovaccer is committing $250 million to expand its AI agent platform, which automates workflows across areas like prior authorization, revenue cycle management and population health. The move comes amid an ongoing debate over whether administrative AI tools can ultimately reduce costs for providers. The post Why Innovaccer Is Pouring $250M into Its Agentic AI Platform…
Employer-Sponsored Health Insurance 101
This Health Policy 101 chapter explores employer-sponsored health insurance (ESI), the primary health coverage source for U.S. residents under age 65. In addition to detailing ESI requirements and incentives, structure, availability, and costs, the chapter examines ongoing challenges related to affordability and access to care for those with ESI coverage.
Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors
Eli Lilly is paying up to $300 million for CrossBridge Bio, a startup developing antibody drug conjugates that deliver two drug payloads to cancers. Beyond potentially better efficacy, CrossBio’s dual approach could also fight drug resistance. The post Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors appeared first on…
Implications of AI Chatbots Performing Poorly at Differential Diagnosis
Mass General Brigham’s Marc Succi, M.D., discusses his team’s study involving 21 large language models
From Insight to Intervention: Why Over-the-Counter Digital Therapeutics (ODTx) are the Next Step for LLMs and Wearables
These products have yet to offer treatment solutions designed to get users from their current health state to a desired future health state. This creates a massive, untapped opening for tools that move people from awareness to action in a clinically meaningful way, without the cost and access barriers of engaging the healthcare system or requiring…
The Last Mile Problem in AI Radiology: Detection Improves, Follow-Through Breaks
The next wave of radiology AI value will come from closed-loop follow-up. An actionable finding should start a pathway with a measurable end state: the follow-up exam is completed, the referral is completed, or the recommendation is clinically resolved with a documented rationale. The post The Last Mile Problem in AI Radiology: Detection Improves, Follow-Through…
